Stroke prevention in elderly patients with atrial fibrillation

Singapore Medical Journal

Volumn 43, Issue 4, 2002, Pages 198-201

  Lew, S J W ^a   Lim, J K H ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Anticoagulation; Arrhythmia; Atrial fibrillation; Elderly; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; TICLOPIDINE; WARFARIN;

AGE; AGED; ANEMIA; ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPEPSIA; ELDERLY CARE; ELECTROCARDIOGRAM; FALLING; FEMALE; GERIATRIC CARE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PEPTIC ULCER; PREVALENCE; RECURRENCE RISK; RISK BENEFIT ANALYSIS; RISK FACTOR; STROKE; TERMINAL DISEASE; TREATMENT CONTRAINDICATION;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PREVALENCE; RISK FACTORS; WARFARIN;

EID: 0036306975     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution and gender of patients with atrial fibrillation Analysis and implications. Arch Intern Med 1995; 155:469-73.
2. Wolf PA, Abbott RD, Kannel WB. Atrial Fibrillation as an independent risk factor for stroke The Framingham Study. Stroke 1991; 22(8):983-8.
3. Phillips SJ, Whisnant JP, O'Fallon WM, Frye PL. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 1990; 65(3):344-59.
4. Lake FR, Cullen KJ, de Klerk NH, McCall MG Rosman DL. Atrial fibrillation and mortality in an elderly population. Aust N Z Med 1989, 19(4):321-6.
5. Furberg CD, Psaty BM, Manoliu TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (The Cardiovascular Health Study) Am J Cardiol 1994; 74(3):236-41.
6. Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CT. Long-term survival after first ever stroke: the Oxfordshire Community Stroke Project Stroke 1 993; 24(6):796-800.
7. Petersen P, Boysen G, Godfredsen J, Andersen B. Placebo controlled, randomised trial of warfarin and aspirin for the prevention of thromboembolic complications of chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989; 177:175-9
8. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low dose warfarin on the risk of stroke in patients with non rheumatic atrial fibrillation. N Engl J Med 323(22):1505-1
9. Connolly SJ, Laupacis A, Gent M, Robert RS, Cairns JA, Joyner C. Canadian atrial fibrillation anticoagulation (CAFA) Study. J Am Coll Cardiol 1991, 19349-51.
10. European Atrial Fibrillation Trial Study Group. Secondary prevention in non rheumatic atrial fibrillation after transient ischaemic attack and minor stroke Lancet 1993, 342:1255-62
11. Stroke prevention in atrial fibrillation investigators Stroke Prevention in Atrial Fibrilation Circulation 1991; 84.527-39.
12. Atrial fibrillation investigators, Risk Factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation, analysis of pooled data from five randomised controlled trials Arch Intern Med 1994, 154.1443-8.
13. Stafford RS, Singer DE. National pattern of warfarin usage in atrial fibrillation Arch Intern Med 1996; 156 2357-541.
14. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsutsuki RT Why do patients with atrial fibrillation not receive warfarin. Arch Intern Med 2000, 160.41-6
15. Laupacis A, Albers G Dunn MI, Feinberg WM Antithrombotic therapy in atrial fibrillation Chest 1992; 102.426S-33S.
16. English KM, Channer KS Managing atrial fibrillation in elderly people. Br Med J 1999; 318.1088-9
17. Singer DE. Randomised trials of warfarin for atrial fibrillation, N Eng J Med 1995; 222.54-5
18. Lip GY, Tean KY, Dunn FG Treatment of atrial fibrillation in a district general hospital Br Heart J 1994, 71:92-5
19. Gottleib LK, Salein-Schatz S Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in clinical practice Arch Intern Med 1995; 154:1945-53.
20. Gurwitz JH, Monette J, Rochon PA, Eckler MA, Avorn J. Atrial fibrillation and stroke prevention with warfarin in the long term care setting. Arch Intern Med 1997, 157:978-84
21. Stroke Prevention In Atrial Fibrillation Investigators. Patients with non valvular atrial fibrillation at low risk of stroke during treatment with aspirin, Stroke Prevention in Atrial Fibrillation III Study, JAMA 1998; 279(16):1273-77.
22. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation. stroke Prevention in Atrial Fibrillation II Study Lancet 1994, 343:687-91